These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9583683

  • 1. Molecular analysis of the FHIT gene in human prostate cancer.
    Latil A, Bièche I, Fournier G, Cussenot O, Pesche S, Lidereau R.
    Oncogene; 1998 Apr 09; 16(14):1863-8. PubMed ID: 9583683
    [Abstract] [Full Text] [Related]

  • 2. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P, Wilhelm M, Kovacs G.
    Genes Chromosomes Cancer; 1997 Sep 09; 20(1):9-15. PubMed ID: 9290948
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.
    Cancer Res; 1997 Sep 01; 57(17):3664-8. PubMed ID: 9288768
    [Abstract] [Full Text] [Related]

  • 4. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
    Michael D, Beer DG, Wilke CW, Miller DE, Glover TW.
    Oncogene; 1997 Oct 02; 15(14):1653-9. PubMed ID: 9349498
    [Abstract] [Full Text] [Related]

  • 5. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR.
    Cancer Res; 1997 Nov 01; 57(21):4692-8. PubMed ID: 9354423
    [Abstract] [Full Text] [Related]

  • 6. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
    Yu HG, Shun LB, Luo HS, Huang H, Yu BP, Yu JP, Meier JJ, Schrader H, Bastian A, Schmitz F, Schmidt WE.
    Int J Colorectal Dis; 2002 Nov 01; 17(6):396-401. PubMed ID: 12355215
    [Abstract] [Full Text] [Related]

  • 7. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 8. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT, Lei J, Shi YQ, Yin J, Wang S, Souza RF, Kong D, Shimada Y, Smolinski KN, Greenwald BD, Abraham JM, Harpaz N, Meltzer SJ.
    Oncogene; 1997 Jul 03; 15(1):101-5. PubMed ID: 9233782
    [Abstract] [Full Text] [Related]

  • 9. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B, Grebe SK, Wang L, Hay ID, Yokomizo A, Liu W, Goellner JR, Grant CS, Smith DI, Eberhardt NL.
    Clin Endocrinol (Oxf); 2000 Jun 03; 52(6):749-57. PubMed ID: 10848880
    [Abstract] [Full Text] [Related]

  • 10. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
    Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM.
    Cancer Res; 1996 Jul 15; 56(14):3173-9. PubMed ID: 8764101
    [Abstract] [Full Text] [Related]

  • 11. Induction of the common fragile site FRA3B does not affect FHIT expression.
    Michael D, Rajewsky MF.
    Oncogene; 2001 Mar 29; 20(14):1798-801. PubMed ID: 11313927
    [Abstract] [Full Text] [Related]

  • 12. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L, Khan MA, Freedman AN, Gemma A, Rusin M, Guinee DG, Bennett WP, Caporaso NE, Fleming MV, Travis WD, Colby TV, Trastek V, Pairolero PC, Tazelaar HD, Midthun DE, Liotta LA, Harris CC.
    Cancer Res; 1998 Jun 15; 58(12):2533-6. PubMed ID: 9635574
    [Abstract] [Full Text] [Related]

  • 13. Study of FHIT transcripts in normal and malignant breast tissue.
    Bièche I, Latil A, Becette V, Lidereau R.
    Genes Chromosomes Cancer; 1998 Dec 15; 23(4):292-9. PubMed ID: 9824201
    [Abstract] [Full Text] [Related]

  • 14. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A, Srinivasan R, Shabnam MS, Majumdar S, Joshi K, Behera D.
    Mol Cancer Res; 2006 Feb 15; 4(2):93-9. PubMed ID: 16513840
    [Abstract] [Full Text] [Related]

  • 15. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ, Keck-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC.
    Cancer Res; 2000 Feb 15; 60(4):1049-53. PubMed ID: 10706123
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
    Genes Chromosomes Cancer; 1997 Sep 15; 20(1):98-102. PubMed ID: 9290961
    [Abstract] [Full Text] [Related]

  • 17. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T, Sasagawa T, Yamazaki H, Sakaike J, Ishikawa H, Inoue M.
    Cancer; 1999 May 01; 85(9):2001-10. PubMed ID: 10223242
    [Abstract] [Full Text] [Related]

  • 18. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID, Szeles A, Yang Y, Klein G, Imreh S.
    Cancer Res; 2000 Dec 15; 60(24):7119-25. PubMed ID: 11156420
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
    Yanagisawa K, Kondo M, Osada H, Uchida K, Takagi K, Masuda A, Takahashi T, Takahashi T.
    Cancer Res; 1996 Dec 15; 56(24):5579-82. PubMed ID: 8971157
    [Abstract] [Full Text] [Related]

  • 20. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
    Simon B, Bartsch D, Barth P, Prasnikar N, Münch K, Blum A, Arnold R, Göke B.
    Cancer Res; 1998 Apr 15; 58(8):1583-7. PubMed ID: 9563464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.